Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review

Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: Relationship to disease severity

(2012) Rekha Chaudhuri et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer

(2012) Alicia F.C. Okines et al.   Therapeutic Advances in Gastroenterology

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

(2011) Katrin M Sjoquist et al.   LANCET ONCOLOGY

Levels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer

(2011) Ozgur Kemik   WORLD JOURNAL OF GASTROENTEROLOGY

ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial

(2010) A. C. Vilmar et al.   ANNALS OF ONCOLOGY

Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer

(2010) C. Frederiksen et al.   ANNALS OF ONCOLOGY

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) A. Okines et al.   ANNALS OF ONCOLOGY

7th Edition of the AJCC Cancer Staging Manual: Stomach

(2010) Kay Washington   ANNALS OF SURGICAL ONCOLOGY

HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion

(2010) Wei Bao et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

NSABP B-30: definitive analysis of patient outcome from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclophosphamide in women with operable, node-positive breast cancer.

(2010) SM Swain et al.   CANCER RESEARCH

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

(2010) Kai Kessenbrock et al.   CELL

Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: A prospective validation study

(2010) Helgi Birgisson et al.   EUROPEAN JOURNAL OF CANCER

Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients

(2009) Barbara Mroczko et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer

(2009) Takaki Yoshikawa et al.   Gastric Cancer

HER2,TOP2A, and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients

(2009) Bent Ejlertsen et al.   JOURNAL OF CLINICAL ONCOLOGY

TIMP-1 as a tumor marker in breast cancer – An update

(2008) Sidse Ø Würtz et al.   ACTA ONCOLOGICA

TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro

(2008) Rebecca L. H. Bigelow et al.   BREAST CANCER RESEARCH AND TREATMENT

KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

(2008) Astrid Lièvre et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer

(2008) Nanna Møller Sørensen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

A Comparative Study of Tissue Inhibitor of Metalloproteinases-1 Levels in Plasma and Tumour Tissue from Patients with Primary Breast Cancer and in Plasma from Patients with Metastatic Breast Cancer

(2008) Anne-Sofie Schrohl et al.   TUMOR BIOLOGY